Immunohistochemical expression of excision repair cross-complementing 1 (ERCC1) in non-small-cell lung cancer: implications for patient outcome


ÇUBUKÇU E. , Olmez O. F. , SARAYDAROĞLU Ö. , Akcali U., Kanat O., Kurt E., ...More

CLINICAL & TRANSLATIONAL ONCOLOGY, vol.13, no.11, pp.826-830, 2011 (Journal Indexed in SCI) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 13 Issue: 11
  • Publication Date: 2011
  • Doi Number: 10.1007/s12094-011-0741-7
  • Title of Journal : CLINICAL & TRANSLATIONAL ONCOLOGY
  • Page Numbers: pp.826-830

Abstract

The identification of novel prognostic markers may help to better assess survival probability in different subgroups of patients with non-small-cell lung cancer (NSCLC) and to tailor treatment according to the molecular profile of the tumour.